# Long-term Safety and Tolerability of AFFITOPE AD02

> **NCT00711321** · — · COMPLETED · sponsor: **Affiris AG** · enrollment: 23 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00711321
- **Lead sponsor:** Affiris AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2010-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711321, "Long-term Safety and Tolerability of AFFITOPE AD02". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00711321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*